ASYMCHEM(06821.HK): 2026 Nine-Month Report - Profit Attributable to Shareholders stood at CNY 852.19 million, YoY increase of 6.49%

NewTimeSpace News: October 22, 2026, ASYMCHEM(06821.HK) released its Nine-Month Report for the period ended December 31, 2026, Total Revenue stood at CNY 5.39 billion, increased by 16.52% YoY; Net Profit stood at CNY 843.13 million, YoY increase of 6.39%; Profit Attributable to Shareholders stood at CNY 852.19 million, YoY increase of 6.49%; Basic Earnings Per Share (EPS) stood at CNY 2.36.

In terms of profitability, ASYMCHEM Gross Profit changed from CNY 1.96 billion in the same period last year to CNY 2.24 billion in the current period, increased by CNY 286.22 million; gross profit margin changed from 42.23% in the same period last year to 41.55% in the current period, decreased by 0.68 percentage points; net profit changed from CNY 792.48 million in the same period last year to CNY 843.13 million in the current period, increased by CNY 50.65 million; net profit margin changed from 17.12% in the same period last year to 15.63% in the current period, decreased by 1.49 percentage points. 

In terms of earnings quality, ASYMCHEM Operating Profit changed from CNY 916.2 million in the same period last year to CNY 863.1 million in the current period, decreased by CNY 53.1 million; Operating Profit Margin changed from 19.79% in the same period last year to 16% in the current period, decreased by 3.79 percentage points; Net Cash Flow from Operating Activities changed from cash inflow of CNY 1.14 billion in the same period last year to cash inflow of CNY 605.32 million in the current period, decreased by CNY 538.84 million; Ratio of Net Cash Flow from Operating Activities to Total Operating Revenue changed from 24.71% in the same period last year to 11.22% in the current period, decreased by 13.49 percentage points. 

In terms of financial soundness, ASYMCHEM Debt-to-Asset Ratio changed from 12.35% in the same period last year to 17.67% in the current period, increased by 5.32 percentage points; Total Equity changed from CNY 17.36 billion in the same period last year to CNY 17.811 billion in the current period, increased by CNY 450.5 million; Cash and Cash Equivalents changed from CNY 3.72 billion in the same period last year to CNY 3.299 billion in the current period, decreased by CNY 421.24 million; Current Liabilities changed from CNY 1.78 billion in the same period last year to CNY 2.62 billion in the current period, increased by CNY 840.52 million; Quick Ratio changed from 5.53 in the same period last year to 3.57 in the current period, decreased by 1.96 percentage points. 

In terms of R&D investment focus, ASYMCHEM R&D Expenses changed from CNY 433.07 million in the same period last year to CNY 355.67 million in the current period, decreased by CNY 77.4 million; R&D to Total Revenue Ratio changed from 9.35% in the same period last year to 6.59% in the current period, decreased by 2.76 percentage points. 

By the close of trading on October 22, 2026, ASYMCHEM(06821) saw a loss of 10.66% in its share price, closing at HKD 119.8 and touched an intraday low of HKD 118.4. The full-day turnover stood at HKD 145.68 million, showing significant volume increase, with the latest market capitalization at HKD 3.33 billion.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.